14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
TME vs META: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
META Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)
META Overall Winner
6-Pillar Tally: TME 2 – 4 META
Matrix Metrics: TME 3 – 7 META
As of Nov 16, 2026, Meta Platforms, Inc. (META) is the stronger overall head-to-head candidate over Tencent Music Entertainment Group (TME) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). TME carries a Unified Composite Score of 52.1/100 (HOLD) at $8.85 (9.1x Forward P/E, 29.7% operating margin), whereas META carries 68.7/100 (BUY) at $624.18 (18.9x Forward P/E, 37.8% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TME vs META. Trailing 12-month operating profitability (TME 29.7% vs META 37.8%) and valuation multiples (TME 9.1x vs META 18.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Investor FAQ TME vs META Key Questions & Quantitative Answers
As of Nov 16, 2026, Meta Platforms, Inc. (META) is the stronger overall head-to-head candidate over Tencent Music Entertainment Group (TME) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). TME carries a Unified Composite Score of 52.1/100 (HOLD) at $8.85 (9.1x Forward P/E, 29.7% operating margin), whereas META carries 68.7/100 (BUY) at $624.18 (18.9x Forward P/E, 37.8% operating margin). Technically, TME sits in a Markup phase (RSI 51.1, UNCLASSIFIED options structure) and META sits in a Neutral phase (RSI 43.9, CONSOLIDATION options structure).
META leads the Growth & Scale pillar: TME posts +5.8% YoY revenue growth and +2.4% YoY earnings growth on $5.09B TTM revenue (44.3% gross margin, 29.7% operating margin), compared with META at +26.1% YoY revenue growth and +264.8% YoY earnings growth on $241.6B TTM revenue (81.0% gross margin, 37.8% operating margin). On trailing 12-month operating scale, TME generates $5.09B in USD-normalized revenue versus $241.6B for META. In operating R&D and SG&A reinvestment, TME deploys 14.6% of Rev ($742M) (0 90-day corporate R&D disclosures) versus 43.2% of Rev ($104.4B) (9 disclosures) for META.
TME screens cheaper on headline valuation multiples. TME trades at 9.1x Forward P/E, 11.0x Trailing P/E, 0.94x PEG, and 2.9x EV/Revenue (33.2% EBITDA margin), whereas META trades at 18.9x Forward P/E, 21.3x Trailing P/E, 0.82x PEG, and 7.0x EV/Revenue (11.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against TME (11.0% ROE) versus META (32.3% ROE) capital efficiency.
In options market volatility and institutional positioning, TME carries 38.5% implied volatility (3rd %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.56β · 33% Vol realized risk). By comparison, META carries 43.0% implied volatility (49th %ile, Balanced (25th–60th %ile)), a 0.41x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.43β · 40% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.